BRAF and thyroid nodule: In our series, K601E-mutant FV-PTC showed no aggressive features, such as extrathyroidal extension, vascular invasion, or metastases, supporting the notion that BRAF p.K601E mutated thyroid nodules are typically indolent, in contrast to BRAF p.V600E mutated carcinomas [23,24].